Novartis Says Therapy LDK378 Shows Marked Clinical Response

Novartis Says Therapy LDK378 Shows Marked Clinical Response

Filed under: drug rehab treatment options

In March, LDK378 received Breakthrough Therapy designation from the US Food and Drug Administration. The designation is intended to expedite the development and review of drugs that treat life-threatening conditions and show improvement over …
Read more on RTT News

Galena Biopharma Provides Product Pipeline Update at the ASCO 2013 Annual …

Filed under: drug rehab treatment options

NeuVax targets the approximately 50%-60% of these women who are HER2 negative (IHC 1+/2+ or FISH < 2.2) and achieve remission with current standard of care, but have no available HER2-targeted adjuvant treatment options to maintain their …
Read more on GlobeNewswire (press release)

NeuroDerm Awarded M by The Michael J. Fox Foundation for the Clinical …

Filed under: drug rehab treatment options

NeuroDerm, Ltd. was informed today that it was awarded, for the second time, a grant of $ 1M by The Michael J. Fox Foundation for Parkinson's Research (MJFF) to support the clinical development of its subcutaneously delivered drug for the treatment of …
Read more on PR Newswire (press release)